1. Home
  2. CYTK vs WMS Comparison

CYTK vs WMS Comparison

Compare CYTK & WMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$69.27

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Advanced Drainage Systems Inc.

WMS

Advanced Drainage Systems Inc.

HOLD

Current Price

$135.08

Market Cap

10.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
WMS
Founded
1997
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.2B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
CYTK
WMS
Price
$69.27
$135.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
8
Target Price
$89.26
$180.63
AVG Volume (30 Days)
1.7M
977.5K
Earning Date
05-05-2026
05-21-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
5.44
Revenue
$13,368,000.00
$3,050,376,000.00
Revenue This Year
$7.37
$5.23
Revenue Next Year
$310.19
$12.79
P/E Ratio
N/A
$23.81
Revenue Growth
N/A
5.03
52 Week Low
$31.99
$109.63
52 Week High
$80.20
$179.32

Technical Indicators

Market Signals
Indicator
CYTK
WMS
Relative Strength Index (RSI) 45.21 44.00
Support Level $59.07 $131.89
Resistance Level $70.69 $146.04
Average True Range (ATR) 2.87 3.75
MACD -1.15 -0.08
Stochastic Oscillator 25.26 28.83

Price Performance

Historical Comparison
CYTK
WMS

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About WMS Advanced Drainage Systems Inc.

Advanced Drainage Systems Inc is the manufacturer of water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Its products are used across a broad range of end markets and applications, including residential, non-residential, infrastructure and agriculture applications. It operates business in three distinct reportable segments: Pipe; International, and Infiltrator. It generates a greater proportion of revenue from its Pipe segment, which consists of Pipe product sales in the United States. The Infiltrator is a provider of plastic leachfield chambers and systems, septic tanks and accessories, for use in residential applications.

Share on Social Networks: